ELOVL Fatty Acid Elongase 5 (ELOVL5) (Middle Region) Peptid
Kurzübersicht für ELOVL Fatty Acid Elongase 5 (ELOVL5) (Middle Region) Peptid (ABIN8099571)
Target
Spezies
Quelle
Applikation
-
-
Protein Region
- Middle Region
-
Verwendungszweck
- ELOVL5 Peptide - middle region
-
Sequenz
- VFWPCSFPLG WLFFQIGYMI SLIALFTNFY IQTYNKKGAS RRKDHLKGHQ
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Kommentare
-
This is a synthetic peptide designed for use in combination with anti- ELOVL5 Antibody (ARP90420_P050),. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Add 100 µL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Buffer
- Lyophilized powder
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- For longer periods of storage, store at -20 °C. Avoid repeat freeze-thaw cycles.
-
-
- ELOVL5 (ELOVL Fatty Acid Elongase 5 (ELOVL5))
-
Hintergrund
-
Background Information: Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Condensing enzyme that acts specifically toward polyunsaturated acyl-CoA with the higher activity toward C18:3(n-6) acyl-CoA. May participate in the production of monounsaturated and of polyunsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators.
Alternative Symbols: HELO1, AI747313, AU043003, 1110059L23Rik
-
Molekulargewicht
- 32 kDa
-
Gen-ID
- 68801
-
NCBI Accession
- NP_599016
-
UniProt
- Q8BHI7
Target
-